CTI BioPharma (NASDAQ:CTIC) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other research analysts have also recently weighed in on CTIC. Lake Street Capital cut shares of CTI BioPharma from a buy […]

Related Keywords

Zurcher Kantonalbank Zurich Cantonalbank ,Stifel Nicolaus ,Fund Management Co ,Proshare Advisors ,Needham Company ,Pricet Rowe Associates Inc ,Principal Financial Group Inc ,Biopharma Corp ,Get Rating ,Street Capital ,Pharma Price ,Share Advisors ,Fund Management ,Financial Group ,Kantonalbank Zurich Cantonalbank ,Pharma Daily ,